(Total Views: 512)
Posted On: 01/28/2021 6:58:09 PM
Post# of 155794
Re: Cassandra X #74862
Thank you for your responses correcting my statements. I knew I should have expressed those thoughts as questions.
The bottom line the purpose of my post, was to understand when we "might" hear mainly, the number of placebo deaths and the number of LL group death, obviously as that is the most probable data leading to an EUA for us. Was it December 16th that we reached full enrollment of 390?
Shouldn't Amerix be locking and unblinding the data very very soon. I know we don't want to set high expectations, but that is the BIG QUESTION.
I understand Secondary Endpoints "can" possibly help us cross that line to an EUA, if the p value for the Primary Endpoint is at or slightly above 0.05
So it seems that data may still not be unblinded. Computers organize the data, not people, so even Amerix folks have not seen data. Computers clean it, validate it, then data is locked, then it is unblinded? I delve into too many things & hobbies that I don't really take enought time to thoroughly understand or master.
The bottom line the purpose of my post, was to understand when we "might" hear mainly, the number of placebo deaths and the number of LL group death, obviously as that is the most probable data leading to an EUA for us. Was it December 16th that we reached full enrollment of 390?
Shouldn't Amerix be locking and unblinding the data very very soon. I know we don't want to set high expectations, but that is the BIG QUESTION.
I understand Secondary Endpoints "can" possibly help us cross that line to an EUA, if the p value for the Primary Endpoint is at or slightly above 0.05
So it seems that data may still not be unblinded. Computers organize the data, not people, so even Amerix folks have not seen data. Computers clean it, validate it, then data is locked, then it is unblinded? I delve into too many things & hobbies that I don't really take enought time to thoroughly understand or master.
(3)
(0)
